Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanosphere. Part 2: Simultaneous release of a drug and a prodrug (clindamycin and clindamycin phosphate)

Colloids and Surfaces B: Biointerfaces

Volumn 82, Issue 2, 2011, Pages 414-421

  Vukomanović, Marija ^a,b   Škapin, Srečo Davor ^b   Poljanšek, Ida ^c   Žagar, Ema ^c   Kralj, Bogdan ^b   Ignjatović, Nened ^a   Uskoković, Dragan ^a  

^a INSTITUTE OF TECHNICAL SCIENCES   (Serbia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

Author keywords

Controlled release; PLGA HAp core shells; Prodrugs; Prolonged release; Simultaneous release

Indexed keywords

CONTROLLED RELEASE; CORE SHELL; PRODRUGS; PROLONGED RELEASE; SIMULTANEOUS RELEASE;

APATITE; CHEMICAL PROPERTIES; DEGRADATION; DRUG PRODUCTS; HYDROXYAPATITE; ORGANIC POLYMERS;

SHELLS (STRUCTURES);

CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; DRUG CARRIER; HYDROXYAPATITE; NANOSPHERE; POLYGLACTIN; POLYGLACTIN HYDROXYAPATITE CORE SHELL NANOSPHERE; PRODRUG; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DEGRADATION KINETICS; GLASS TRANSITION TEMPERATURE; IN VITRO STUDY; MOLAR MASS; MOLECULAR SIZE; MORPHOLOGY; NANOENCAPSULATION; POROSITY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ADSORPTION; ANTI-BACTERIAL AGENTS; CALORIMETRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLINDAMYCIN; DRUG DELIVERY SYSTEMS; HUMANS; HYDROXYAPATITES; LACTIC ACID; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; NANOSPHERES; NANOTECHNOLOGY; POLYGLYCOLIC ACID; PRODRUGS; SURFACE PROPERTIES; ULTRASONICS;

EID: 78649446170     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.09.012     Document Type: Article

References (49)

1. Campoccia D., Baldassarri L., Pirini V., Ravaioli S., Montanaro L., Arciola C.R. Biomaterials 2008, 29:4108.
2. Ostermann P.A., Henry S.L., Seligson D. Clin. Orthop. 1993, 295:102.
3. Ostermann P.A., Henry S.L., Seligson D. Orthopedics 1994, 17(5):397.
4. Leach W.J., Wilson N.I. J. R. Coll. Surg. Edinb. 1992, 37(4):265.
5. Briones E., Colino C.I., Lanao J.M. J. Control. Release 2008, 125:210.
6. Dash A.K., Cudworth G.C. J. Pharmacol. Toxicol. Methods 1998, 40(1):1.
7. Branco M.C., Schneider J.P. Acta Biomater. 2009, 5:817.
8. Hatefi A., Amsden B. J. Control. Release 2002, 80:9.
9. Hendriks J.G.E., van Horn J.R., van der Mei H.C., Busscher H.J. Biomaterials 2004, 25:545.
10. van de Belt H., Neut D., van Horn J.R., van der Mei H.C., Schenk W., Busscher H.J. Nat. Med. 1999, 5:358.
11. Doshi N., Mitragotri S. Adv. Funct. Mater. 2009, 19:3843.
12. Design of Controlled Release Drug Delivery Systems 2006, The McGraw-Hill Companies Inc., USA. X. Li, B.R. Jasti (Eds.).
13. Gold H.S., Pillai S.K. Infect. Dis. Clin. North Am. 2009, 23(1):99.
14. Su B., Wang Z., Wang J., Wang S. J. Membr. Sci. 2005, 251:189.
15. Thomas S., Stevenson M., Riley T.V. J. Antimicrob. Chemother. 2003, 51:1339.
16. Stella V.J., Nti-Addae K.W. Adv. Drug Deliv. Rev. 2007, 59:677.
17. Ackaert O.W., De Graan J., Capancioni R., Della Pasqua O.E., Dijkstra D., Westerink B.H., Danhof M., Bouwstra J.A. J. Control. Release 2010, 144:296.
18. Gilad J.Z., Teles R., Goodson M., White R.R., Stashenko P. J. Endod. 1999, 25(11):722.
19. M. Abdennour, P. Stashenko, M. Scrime, J. Gilad, M. Goodson, US Patent No. 7331787 (2008).
20. J.A. Halliday, D.A. Carr, L. Boyd, M. Macgregor, A. Thom, L. Kelly, M.A. Livingstone, L.M. Currie, WO/2008/007098 (2008).
21. L.H. Calhoun, J.T. Mader, US Patent No. 5268178 (1993).
22. Cimbollek M., Nies B., Liebendorfer A., Wenz R., Kreuter J. J. Control. Release 1995, 33:47.
23. Okuda T., Tominaga K., Kidoaki S. J. Control. Release 2010, 143:258.
24. Shi M., Yang Y.-Y., Chaw C.-S., Goh S.-H., Moochhala S.M., Ng S., Heller J. J. Control. Release 2003, 89:167.
25. Lo C.T., van Tassel P.R., Saltzman W.M. Biomaterials 2009, 30:4889.
26. Virto M.R., Elorza B., Torrado S., Elorza M.L.A., Frutos G. Biomaterials 2007, 28:877.
27. Vukomanović M., Škapin S.D., Jančar B., Maksin T., Ignjatović N., Uskoković V., Uskoković D. Colloids Surf. B 2010, 82:404.
28. Jevtić M., Radulović A., Ignjatović N., Mitrić M., Uskoković D. Acta Biomater. 2009, 5:208.
29. Jevtić M., Mitrić M., Škapin S., Jančar B., Ignjatović N., Uskoković D. Cryst. Growth Des. 2008, 8(7):2217.
30. Wang S.-M., Bu S.-S., Liu H.-M., Li H.-Y., Liu W., Wang Y.-D. Rapid Commun. Mass Spectrom. 2009, 23:899.
31. Hausberger A.G., DeLuca P.P. J. Pharm. Biomed. 1995, 13:747.
32. Vukomanović M., Mitrić M., Škapin S.D., Žagar E., Plavec J., Ignjatović N., Uskoković D. Ultrason. Sonochem. 2010, 17:902.
33. The Practice of Medicinal Chemistry 2003, Elsevier, Amsterdam. C.G. Wermuth (Ed.).
34. Prodrugs Challenges and Rewards Part I 2007, Springer, New York. V.J. Stella, R.T. Borchardt, M.J. Hageman, R. Oliyai, H. Maag, J.W. Tilley (Eds.).
35. Brazel C.S., Pappas N.A. Polymer 1999, 40:3383.
36. Berkland C., Kim K.K., Pack D.W. Pharm. Res. 2003, 20:1055.
37. Kumari A., Yadav S.K., Yadav S.C. Colloids Surf. B 2010, 75:1.
38. Huang X., Brazel C.S. J. Control. Release 2001, 73:121.
39. Govender T., Stolnik S., Garnett M.C., Illum L., Davis S.S. J. Control. Release 1999, 57:171.
40. Lee Y.-H., Mei F., Bai M.-Y., Zhao S., Chen D.-R. J. Control. Release 2010, 145:58.
41. Lee T.H., Wang J., Wang C.-H. J. Control. Release 2002, 83:437.
42. Xu Q., Czernuszka J.T. J. Control. Release 2008, 127:146.
43. Vey E., Roger C., Meehan L., Booth J., Claybourn M., Miller A.F., Saiani A. Polym. Degrad. Stab. 2008, 93:1869.
44. Siepmann J., Elkharraz K., Siepmann F., Klose D. Biomacromolecules 2005, 6:2312.
45. Kang J., Schwendeman S.P. Biomaterials 2002, 23:239.
46. Kluin O.S., van der Mei H.C., Busscher H.J., Neut D. Biomaterials 2009, 30:4738.
47. Schiller C., Epple M. Biomaterials 2003, 24:2037.
48. Ho M.L., Fu Y.C., Wang G.J., Chen H.T., Chang J.K., Tsai T.H., Wang C.K. J. Control. Release 2008, 128:142.
49. Yang Z., Best S.M., Cameron R.E. Adv. Mater. 2009, 21:3900.